4.5 Article

Processing and secretion of ROP13: A unique Toxoplasma effector protein

Journal

INTERNATIONAL JOURNAL FOR PARASITOLOGY
Volume 40, Issue 9, Pages 1037-1044

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ijpara.2010.02.014

Keywords

Toxoplasma gondii; ROP13; Rhoptry; Effector protein; Host-pathogen

Categories

Funding

  1. Microbial Pathogenesis Training [T32-AI07323]
  2. NIH [1R01AI064616]

Ask authors/readers for more resources

Like most intracellular pathogens, Toxoplasma synthesizes and secretes an arsenal of proteins to successfully invade its host cell and hijack host functions for intracellular survival. The rhoptries are key secretory organelles that inject proteins into the host cell where they are positioned to co-opt host processes, although little is known regarding how these proteins exert their functions. We show here that the rhoptry protein ROP13 is synthesized as a pre-pro-protein that is processed in the parasite. Processing occurs at a conserved S phi XE cleavage site as mutagenesis of glutamic acid to alanine at the P1 position disrupts ROP13 maturation. We also demonstrate that processing of the prodomain is not necessary for rhoptry targeting and secretion. While gene disruption reveals that ROP13 is not essential for growth in fibroblasts in vitro or for virulence in vivo, we find that ROP13 is a soluble effector protein that can access the cytoplasm of host cells. Exogenously expressed ROP13 in human cells remains cytosolic but also appears toxic, suggesting that over-expression of this effector protein is disrupting some function within the host cell. (C) 2010 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available